EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Ginseng Bioactive Components as Gut-Brain Axis-Targeted Modulators: Therapeutic Potential and Mechanisms in Multifactorial Diseases

Silu Liu iD, Lanshi Tian, Weijia Chen iD, Jianan Geng, Zhongmei He iD, Jia Zhou

Nutrients · 31.05.2026 · 18 (11) · 1778

DOI: 10.3390/nu18111778 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 31.05.2026. Verfasst von Silu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China. Hauptthemen laut MEDLINE: Panax, Brain, Brain-Gut Axis, Plant Extracts. Die Arbeit nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Science and Technology Development Talent Special Project: Study on the key technology and industrialization of chelating calcium from deer tendon under…, Jilin Provincial Science and Technology Development Program Project Task - Jilin Provincial Key Laboratory of International Cooperation on Efficient Breeding a…, Development and industrialization of Antler Ginseng Yizhi tablet, a health food which can im-prove learning and memory function.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ginseng (Panax ginseng C. A. Mey.) is a classic traditional Chinese herbal medicine with a history of clinical use that spans millennia. Its utilisation has long been established in the regulation of physical and mental equilibrium, in addition to the amelioration of conditions pertaining to the heart, spleen, and brain. Recent studies have indicated that the core biological activity of the substance under investigation is mediated by key active components such as ginsenosides, polysaccharides, and polyphenols. These components are closely associated with the regulation of the gut-brain axis (GBA). However, extant reviews have predominantly concentrated on individual diseases or specific mechanisms, thereby lacking a thorough investigation into the comprehensive analysis of how ginseng components exert systemic effects via the GBA. This review systematically searched and analyzed published studies in major databases regarding the regulation of the GBA by ginseng bioactive components, summarizing the latest advances in its role as a multifactorial disease intervention regulator targeting the GBA. It has been demonstrated that ginseng components exert a multifaceted GBA regulatory effect through interconnected mechanisms, including modulation of the gut microbiota, protection of the intestinal barrier, anti-inflammatory actions, and regulation of neurotransmitters, showing promising preclinical therapeutic potential in neurodegenerative diseases, mood disorders, metabolic diseases, and gastrointestinal disorders. Contrary to previous reviews, which focused on the description of individual ginseng components or specific diseases, this study provides a comprehensive analysis of how various bioactive components of ginseng modulate the gut-brain axis in relation to multiple disease categories through a systematic review. However, the preponderance of extant evidence derives from preclinical studies and necessitates further validation through clinical trials. This review provides pivotal directions and theoretical underpinnings for the clinical translation of ginseng’s bioactive components and the development of disease intervention strategies targeting the gut-brain axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PanaxBrainBrain-Gut AxisPlant ExtractsHumansAnimalsGinsenosidesGastrointestinal MicrobiomeNeurodegenerative DiseasesMetabolic DiseasesGastrointestinal DiseasesMood Disorders

Stichwörter der Autor:innen

ginsengginseng polysaccharidesginsenosidesgut microbiotagut-brain axis (GBA)

Substanzen

GinsenosidesPlant Extracts

Autor:innen und Institutionen

  • College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
  • College of Pharmacy, Yanbian University, 997 Park Road, Yanji 133002, China.

ORCID-Profile: Silu Liu, Weijia Chen, Zhongmei He

Förderung

  • Jilin Science and Technology Development Talent Special Project: Study on the key technology and industrialization of chelating calcium from deer tendon under…
  • Jilin Provincial Science and Technology Development Program Project Task - Jilin Provincial Key Laboratory of International Cooperation on Efficient Breeding a…
  • Development and industrialization of Antler Ginseng Yizhi tablet, a health food which can im-prove learning and memory function
  • Jilin Science and Technology Development Talent Special Project
  • Jilin Provincial Science and Technology Development Program

Zitieren

APA

Liu, S., Tian, L., Chen, W., Geng, J., He, Z., & Zhou, J. (2026). Ginseng Bioactive Components as Gut-Brain Axis-Targeted Modulators: Therapeutic Potential and Mechanisms in Multifactorial Diseases. Nutrients, 18(11), 1778. https://doi.org/10.3390/nu18111778

Vancouver

Liu S, Tian L, Chen W, Geng J, He Z, Zhou J. Ginseng Bioactive Components as Gut-Brain Axis-Targeted Modulators: Therapeutic Potential and Mechanisms in Multifactorial Diseases. Nutrients. 2026;18(11):1778. doi:10.3390/nu18111778

BibTeX
@article{Liu2026,
  author = {Liu, Silu and Tian, Lanshi and Chen, Weijia and Geng, Jianan and He, Zhongmei and Zhou, Jia},
  title = {Ginseng Bioactive Components as Gut-Brain Axis-Targeted Modulators: Therapeutic Potential and Mechanisms in Multifactorial Diseases},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1778},
  doi = {10.3390/nu18111778}
}
Kostenlos starten →